(Q50749591)

18 March 2018

title

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus. (English)

1 reference

18 March 2018

0 references

7

Edward W Gregg

1 reference

18 March 2018

Frederick B Dong

1

1 reference

18 March 2018

Stephen W Sorensen

2

1 reference

18 March 2018

Diane L Manninen

3

1 reference

18 March 2018

Theodore J Thompson

4

1 reference

18 March 2018

Venkat Narayan

5

1 reference

18 March 2018

Carlyn E Orians

6

1 reference

18 March 2018

Richard C Eastman

8

1 reference

18 March 2018

Erik J Dasbach

9

1 reference

18 March 2018

William H Herman

10

1 reference

18 March 2018

Jeffrey M Newman

11

1 reference

18 March 2018

Andrew S Narva

12

1 reference

18 March 2018

David J Ballard

13

1 reference

18 March 2018

Michael M Engelgau

14

1 reference

18 March 2018

publication date

1 January 2004

1 reference

18 March 2018

published in

PharmacoEconomics

1 reference

18 March 2018

volume

22

1 reference

18 March 2018

issue

15

1 reference

18 March 2018

page(s)

1015-1027

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.2165/00019053-200422150-00005

exact match

0 references

cites work

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

1 reference

12 December 2020

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

1 reference

12 December 2020

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

12 December 2020

Smoking is associated with progression of diabetic nephropathy

1 reference

12 December 2020

Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function

1 reference

12 December 2020

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

The 10-year incidence of renal insufficiency in people with type 1 diabetes.

1 reference

12 December 2020

Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform.

1 reference

12 December 2020

Magnetic resonance angiography in progressive renal failure: a technology assessment

1 reference

12 December 2020

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

1 reference

12 December 2020

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

12 December 2020

Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Renal protective effect of enalapril in diabetic nephropathy

1 reference

12 December 2020

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

1 reference

12 December 2020

The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM.

1 reference

12 December 2020

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

1 reference

12 December 2020

Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy

1 reference

12 December 2020

Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure: an economic evaluation

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Effect of Angiotensin-Converting Enzyme Inhibition on Renal Function and Albuminuria in Normotensive Type I Diabetic Patients

1 reference

12 December 2020

Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria

1 reference

12 December 2020

Foot infections in diabetic patients. Decision and cost-effectiveness analyses.

1 reference

12 December 2020

Model of complications of NIDDM. I. Model construction and assumptions.

1 reference

12 December 2020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.2165/00019053-200422150-00005

Identifiers

DOI

1 reference

18 March 2018

Dimensions Publication ID

0 references

1 reference

18 March 2018